The pathological mechanism of CML is generally understood as it is dependent on one dominant gene fusion, BCR-ABL (69), whereas each of the other leukaemias are more complex as their mutations occur in many different genes. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.